Skip to main content
VALIRX PLC logo

VALIRX PLC — Investor Relations & Filings

Ticker · VAL ISIN · GB00BLH13C52 LEI · 213800VQKB9SJCQDET40 IL Professional, scientific and technical activities
Open in API
Filings indexed 574 across all filing types
Latest filing 2025-06-09 Regulatory Filings
Country GB United Kingdom
Listing IL VAL

About VALIRX PLC

https://www.valirx.com/

ValiRx PLC is a life science company that accelerates the development of therapeutics and diagnostics, with a primary focus on oncology and women's health. The company's business model centers on identifying and progressing promising early-stage scientific discoveries through pre-clinical and clinical development. ValiRx provides scientific, financial, and commercial expertise to translate novel research into clinically validated treatments, aiming to improve patient outcomes in its target therapeutic areas.

Recent filings

Filing Released Lang Actions
ValiRx Investor Webinar
Regulatory Filings Classification · 1% confidence The document is a short announcement (under 5,000 characters) from ValiRx PLC regarding an upcoming investor webinar. It functions as a notification of an event rather than a primary financial report or presentation itself. Following the 'Menu vs Meal' rule, announcements of events or report publications are classified as RNS (Regulatory Filings) when they do not fit into more specific categories like RPA (which is for report publication specifically). Since this is a general regulatory announcement regarding an investor event, RNS is the most appropriate classification.
2025-06-09 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains fields related to the acquisition or disposal of voting rights, shareholder details, and the date the threshold was crossed (05/06/2025). This format is standard for reporting significant changes in share ownership to a regulatory body (FCA mentioned). This directly corresponds to the definition of Director's Dealing (DIRS) or Major Shareholding Notification (MRQ). Since the form details a change in holding percentage crossing a threshold (from 5.84% to 6.17%), it is a Major Shareholding Notification. The RNS Number and the mention of the FCA confirm it is a regulatory filing concerning ownership changes.
2025-06-06 English
Final Results & Notice of AGM
Interim / Quarterly Report Classification · 1% confidence The document is an 'Annual Results' announcement for ValiRx PLC for the year ended 31 December 2024. It contains key financial highlights (revenue, expenses, loss, cash balance), operational highlights, and a Chairman/CEO report. While it mentions that the full Annual Report has been posted to shareholders, the document itself provides substantive financial data and management analysis, qualifying it as an 'Interim / Quarterly Report' (or in this case, the full Annual Report summary/release). Given the definitions provided, this document serves as the primary financial disclosure for the period. FY 2024
2025-06-06 English
New Evaluation and Material Transfer Agreement
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number' and is dated '03 June 2025'. It announces a specific corporate event: an 'Evaluation and Material Transfer Agreement' between two subsidiaries/companies. The structure, use of RNS headers, and the nature of the announcement (a specific business development update rather than a full financial report, proxy material, or earnings release) strongly suggest this is a general regulatory announcement disseminated via the London Stock Exchange's news service (RNS). Since it is a specific business update that doesn't fit perfectly into categories like M&A (TAR), Capital Change (CAP), or Director's Dealing (DIRS), the most appropriate fallback category for a general regulatory news service release is 'Regulatory Filings' (RNS). The document length is moderate, but the content is purely an announcement of an agreement, not the full report itself, ruling out RPA.
2025-06-03 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Standard form for notification of major holdings', which is a regulatory requirement in the UK for shareholders to disclose when their voting rights in a company cross certain thresholds. This explicitly matches the definition for 'Major Shareholding Notification' (MRQ).
2025-05-20 English
Inaphaea Deal Extension With Dominion
Regulatory Filings Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement from ValiRx PLC regarding a commercial deal extension with Dominion Biotech Ltd. It details a business collaboration, specifically an extension of an evaluation and commercial use agreement. This type of corporate announcement regarding business operations and partnerships falls under the 'Regulatory Filings' (RNS) category as it is a standard market announcement that does not fit into more specific categories like M&A (which usually implies a takeover or merger) or specific financial reports.
2025-05-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.